Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.

@article{Sciarra2011AdvancesIM,
  title={Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.},
  author={Alessandro Sciarra and Jelle O. Barentsz and Anders Bjartell and James Eastham and Hedvig Hricak and Valeria Panebianco and Johannes Alfred Witjes},
  journal={European urology},
  year={2011},
  volume={59 6},
  pages={962-77}
}
CONTEXT Although magnetic resonance imaging (MRI) is emerging as the most commonly used imaging modality for prostate cancer (PCa) detection, treatment planning, and follow-up, its acceptance has not been uniform. Recently, great interest has been shown in multiparametric MRI, which combines anatomic T2-weighted (T2W) imaging with MR spectroscopic imaging (MRSI), dynamic contrast-enhanced MRI (DCE-MRI), and diffusion-weighted imaging (DWI). OBJECTIVE The aim of this article is to review the… CONTINUE READING